Arch Life Sciences Limited, a active public limited company, was established on 15 December 2003 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239TG2003PLC042232. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹3.90 Cr.
Formerly known as Sibra Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Ajit Annu Kamath (Director), Rajendra Padmanabhan Kaimal (Director), Chetan Ajitkumar Shah (Director). Past directors included Sivarama Prasad Manne, Valiveti Brahmaji, Manoor Sayed Husain Sayed. It holds ₹100.00 Cr open charges and ₹7.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No. 8-2-684/J/8/A, Bhavani Nagar, Road No.12 Banjara Hills, Hyderabad, Hyderabad, Telangana, 500034.
U24239TG2003PLC042232
042232
15 December 2003
₹25.00 Cr
₹3.90 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Arch Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Annu Kamath | Director | 02 Apr 2007 | Current |
| Rajendra Padmanabhan Kaimal | Director | 02 Apr 2007 | Current |
| Chetan Ajitkumar Shah | Director | 28 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Dec 2008 | Past |
| Pramod Abcsdd | Director | 13 Feb 2008 | Past |
| Pramod Abcsdd | Additional Director | 29 Mar 2019 | Past |
| Pramod Abcsdd | Director | 15 Jul 2014 | Past |
| Pramod Abcsdd | Director | 15 Mar 2008 | Past |
| Pramod Abcsdd | Additional Director | 29 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arch Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 90.93% decrease. The company also saw a substantial fall in profitability, with a 118.05% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Arch Life Sciences had a promoter holding of 58.46% and a public holding of 41.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000,000.00
₹77,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2008 | State Bank Of India | ₹57.00 Cr | Open |
| 01 Mar 2008 | Indusind Bank Ltd. | ₹15.25 Cr | Open |
| 01 Mar 2008 | State Bank Of Patiala | ₹27.75 Cr | Open |
| 29 Sep 2004 | Uco Bank | ₹7.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Arch Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Arch Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Arch Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Arch Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Chetan Ajitkumar Shah was appointed as a Director was appointed as a Director on 28 Oct 2017 & has been associated with this company since 8 years 1 month . was completed.
The activity A charge with State Bank Of India of Rs. 57.00 Cr registered on 11 Nov 2008 with Charge ID 10136147 was modified on 30 May 2009. was completed.
The activity A charge with State Bank Of India amounted to Rs. 57.00 Cr with Charge ID 10136147 was registered on 11 Nov 2008. was completed.
Progress on A charge with Indusind Bank Ltd. amounted to Rs. 15.25 Cr with Charge ID 10109603 was registered on 01 Mar 2008. was documented.
/PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the....
RBI's corporate debt restructuring cell's failure rate in servicing bad loans in the banking sector was 43% until June against 36% a year ago.
The CIN of Arch Life Sciences Limited is U24239TG2003PLC042232.
Arch Life Sciences Limited is headquartered at D.No. 8-2-684/J/8/A, Bhavani Nagar, Road No.12 Banjara Hills, Hyderabad, Hyderabad, Telangana, 500034.
Arch Life Sciences Limited was incorporated on 15 December 2003.
The current directors of Arch Life Sciences Limited are
The primary industry of Arch Life Sciences Limited is Pharma.
Arch Life Sciences Limited is unlisted.
The authorized capital of Arch Life Sciences Limited is ₹25.00 Cr, and the paid-up capital is ₹3.90 Cr.
The compliance status of Arch Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX